Buy Apto Turinabol (TBOL 10MG) Beligas (international)


  • Power:5/5
  • Mass gain:5/5
  • Oil / Water Loss:0/5
  • Side Effects:2/5
  • Protecting the profit:3/5


Buy Apto Turinabol (TBOL 10MG) Beligas (international)

Buy Apto Turinabol (TBOL 10MG) Beligas (international) Online. This oral steroid is a cross between methandrostenolone and klostebol (4-chloroesthetosterone), which has the same basic structure. As Dianabol with the addition of 4-chloral modifier klostebol.

This change makes chlorodehydromethyltestosterone a lighter cousin of Dianabol, which is much less androgen compared to new steroids that do not have estrogenic activity and more famous etonia. The anabolic activity of chlorodehydromethyltestosterone is also slightly lower than that of Dianabol, but it provides a much more suitable balance between the anabolic effect and an androgenic effect. This means that at the level of any muscle building activity, chlorodehydromethyltestosterone will be less likely to cause androgenic side effects.

Buy Apto Turinabol (TBOL 10MG) Beligas (international)

Side Effects

Although chlorodehydromethyltestosterone is classified as an anabolic steroid, androgenic side effects are still possible with this substance. These may include the growth of oily skin, acne and body/face hair. Chlorodehydromethyltestosterone is a compound with c17-alpha. This modification protects from the liver deactivation of the drug and allows a very high percentage of the drug to enter the bloodstream after oral administration. C17-alpha alkylated anabolic/androgenic steroids can be hepatotoxic. Long-term or high exposure can cause liver damage.


The effective daily dosage is in the range of 6-8 mg taken in cycles not exceeding 15-40 weeks. To minimize hepatotoxicity. This dose is sufficient for an increase in lean muscle mass and strength.


There are no reviews yet.

Be the first to review “Buy Apto Turinabol (TBOL 10MG) Beligas (international)”

Your email address will not be published. Required fields are marked *

You cannot copy content of this page